The immunohistochemical studies demonstrated that the majority of tumor cells were immunoreactive for neuroendocrine markers that included chromogranin A, synaptophysin and neuronspecific enolase.
The newborn screen detects a pancreatic enzyme called IRT, or immunoreactive trypsinogen, which is released into the fetal blood when there is pancreatic damage from CF.